HTGF has participated in a seed round for Kumovis, a spinout of Technical University of Munich that is working on 3D printers for medical technology.

University of Washington has established RNA sequencing technology developer Split Biosciences, which has raised $1.2m in seed funding from unnamed investors.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Sun protection product developer Nanosive has been launched by Truffle Capital with a licence from Yale University.

The newly-founded Oxford cardiovascular imaging spinout raised seed funding from backers including Oxford Sciences Innovation to pursue further product development.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Peptide-based drug developer Navigen has been backed by University of Utah-based student venturing fund UVF II in its first equity round.

KIT-founded valve actuator manufacturer Memetis has received capital from the university and HTGF to help expand development and production.

Meatable has secured the backing of a range of VC investors to commercialise a cultured hamburger based on Cambridge and Stanford patents.